Risk Factors for Esophageal Cancer Development

被引:68
作者
Falk, Gary W. [1 ]
机构
[1] Cleveland Clin, Dept Gastroenterol & Hepatol, Ctr Swallowing & Esophageal Disorders, Cleveland, OH 44195 USA
关键词
Barrett's esophagus; Esophageal adenocarcinoma; Cancer risk; Dysplasia; Gastroesophageal reflux disease; HELICOBACTER-PYLORI INFECTION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HIGH-GRADE DYSPLASIA; BODY-MASS INDEX; GASTROESOPHAGEAL-REFLUX DISEASE; FAMILIAL BARRETT-ESOPHAGUS; SQUAMOUS-CELL CARCINOMA; GASTRIC CARDIA; NEOPLASTIC PROGRESSION; ESOPHAGOGASTRIC JUNCTION;
D O I
10.1016/j.soc.2009.03.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The incidence of esophageal adenocarcinoma is increasing at a rate greater than that of any other cancer in the Western world today. Barrett's esophagus is a clearly recognized risk factor for the development of esophageal adenocarcinoma, but the overwhelming majority of patients with Barrett's esophagus will never develop esophageal cancer. To date, dysplasia remains the only factor useful for identifying patients at increased risk for the development of esophageal adenocarcinoma in clinical practice. Other epidemiologic risk factors include aging, gender, race, obesity, reflux symptoms, smoking, and diet. Factors that may protect against the development of adenocarcinoma include infection with Helicobacter pylori, a diet rich in fruits and vegetables, and consumption of aspirin and NSAIDs.
引用
收藏
页码:469 / +
页数:18
相关论文
共 127 条
[1]   A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma [J].
Abnet, Christian C. ;
Freedman, Neal D. ;
Hollenbeck, Albert R. ;
Fraumeni, Joseph F., Jr. ;
Leitzmann, Michael ;
Schatzkin, Arthur .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (03) :465-471
[2]   Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice [J].
Alikhan, M ;
Rex, D ;
Khan, A ;
Rahmani, E ;
Cummings, O ;
Ulbright, TM .
GASTROINTESTINAL ENDOSCOPY, 1999, 50 (01) :23-26
[3]   Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence:: results from the FINBAR case-control study [J].
Anderson, L. A. ;
Murphy, S. J. ;
Johnston, B. T. ;
Watson, R. G. P. ;
Ferguson, H. R. ;
Bamford, K. B. ;
Ghazy, A. ;
McCarron, P. ;
McGuigan, J. ;
Reynolds, J. V. ;
Comber, H. ;
Murray, L. J. .
GUT, 2008, 57 (06) :734-739
[4]   Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence [J].
Anderson, Lesley A. ;
Johnston, Brian T. ;
Watson, R. G. Peter ;
Murphy, Seamus J. ;
Ferguson, Heather R. ;
Comber, Harry ;
McGuigan, Jim ;
Reynolds, John V. ;
Murray, Liam J. .
CANCER RESEARCH, 2006, 66 (09) :4975-4982
[5]  
Avidan B, 2002, AM J GASTROENTEROL, V97, P1930, DOI 10.1111/j.1572-0241.2002.05902.x
[6]   p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus [J].
Bian, YS ;
Osterheld, MC ;
Fontolliet, C ;
Bosman, FT ;
Benhattar, J .
GASTROENTEROLOGY, 2002, 122 (04) :1113-1121
[7]   ADENOCARCINOMA OF THE ESOPHAGUS AND ESOPHAGOGASTRIC JUNCTION IN WHITE MEN IN THE UNITED-STATES - ALCOHOL, TOBACCO, AND SOCIOECONOMIC-FACTORS [J].
BROWN, LM ;
SILVERMAN, DT ;
POTTERN, LM ;
SCHOENBERG, JB ;
GREENBERG, RS ;
SWANSON, GM ;
LIFF, JM ;
SCHWARTZ, AG ;
HAYES, RB ;
BLOT, WJ ;
HOOVER, RN .
CANCER CAUSES & CONTROL, 1994, 5 (04) :333-340
[8]  
BROWN LM, 1995, J NATL CANCER I, V87, P104, DOI 10.1093/jnci/87.2.104
[9]   Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma [J].
Buttar, NS ;
Wang, KK ;
Sebo, TJ ;
Riehle, DM ;
Krishnadath, KK ;
Lutzke, LS ;
Anderson, MA ;
Petterson, TM ;
Burgart, LJ .
GASTROENTEROLOGY, 2001, 120 (07) :1630-1639
[10]   ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION AND BARRETTS-ESOPHAGUS [J].
CAMERON, AJ ;
LOMBOY, CT ;
PERA, M ;
CARPENTER, HA .
GASTROENTEROLOGY, 1995, 109 (05) :1541-1546